GXO Logistics Inc is a leading global provider of supply chain solutions, specializing in logistics and transportation services. The company focuses on optimizing supply chain operations for a diverse range of industries, leveraging advanced technology and data analytics to enhance efficiency and responsiveness. GXO offers a wide array of services, including warehouse management, last-mile delivery, and integrated logistics solutions, enabling clients to improve their operational performance and meet the increasing demands of e-commerce and retail. With a commitment to innovation and sustainability, GXO aims to transform how goods are managed and delivered across the globe. Read More
Shares of contract logistics company GXO (NYSE:GXO)
jumped 11.3% in the afternoon session after the company provided impressive preliminary financial forecasts and raised its full-year 2025 guidance for organic revenue growth, adjusted EBITDA, and adjusted diluted EPS. This upward revision reflects better-than-expected performance (volumes and accelerated productivity gains) and anticipated gains from the Wincanton acquisition.
GREENWICH, Conn., June 20, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced the appointment of seasoned supply chain leader Patrick Kelleher as its new chief executive officer, effective August 19, 2025.
GREENWICH, Conn., June 19, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced that the UK Competition and Markets Authority (CMA) has cleared GXO’s acquisition of Wincanton subject to the divestment of a small number of Wincanton grocery contracts in the UK, and that integration will be permitted with the vast majority of the Wincanton business once certain administrative conditions are met. The company also announced today that it is raising full-year guidance on organic revenue growth, adjusted EBITDA and adjusted diluted EPS.
Contract logistics company GXO (NYSE:GXO) announced better-than-expected revenue in Q1 CY2025, with sales up 21.2% year on year to $2.98 billion. On the other hand, next quarter’s revenue guidance of $2.97 billion was less impressive, coming in 2.6% below analysts’ estimates. Its non-GAAP profit of $0.29 per share was 14.5% above analysts’ consensus estimates.
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
PARIS, France, May 22, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced a long-term contract renewal and extension with bioMérieux, a world leader in the field of In Vitro Diagnostics providing solutions to improve patient health and to ensure consumer safety.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at air freight and logistics stocks, starting with GXO Logistics (NYSE:GXO).
Growth boosts valuation multiples, but it doesn’t always last forever.
Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
GREENWICH, Conn., May 13, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced the election of five new members to its Board of Directors at its 2025 Annual Meeting of Stockholders. The five new directors join four incumbent directors who were re-elected at the same meeting.
Contract logistics company GXO (NYSE:GXO) announced better-than-expected revenue in Q1 CY2025, with sales up 21.2% year on year to $2.98 billion. On the other hand, next quarter’s revenue guidance of $2.97 billion was less impressive, coming in 2.6% below analysts’ estimates. Its non-GAAP profit of $0.29 per share was 14.5% above analysts’ consensus estimates.
Ten-year $2.5 billion contract with UK’s National Health Service and recent agreement with Siemens Healthineers in the U.S. are springboards for growth
